IPIX

INNOVATION PHARMACEUTICAL by Innovation Pharmaceuticals Inc. (IPIX)

About INNOVATION PHARMACEUTICAL by Innovation Pharmaceuticals Inc. (IPIX)

Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in the development of therapies with anti-infective, oncology, anti-inflammatory, and dermatology applications. It focuses on its antifungal drug candidate called Brilacidin. The company was founded by Krishna Kumar Menon, George W. Evans, and Leo Ehrlich on June 20, 2007 and is headquartered in Wakefield, MA.

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.02
52 Week Low
$0.00
Market cap
537,300
Dividend yield
0.00%
Volume
1.0M
Avg. volume
115,600
P/E ratio
--

INNOVATION PHARMACEUTICAL by Innovation Pharmaceuticals Inc. News

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.02
52 Week Low
$0.00
Market cap
537,300
Dividend yield
0.00%
Volume
1.0M
Avg. volume
115,600
P/E ratio
--